FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FOXA1 | Forkhead box A1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GDF15 | Growth differentiation factor 15 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HMGA2 | High mobility group AT-hook 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HPGD | Hydroxyprostaglandin dehydrogenase 15-(NAD) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
JAG2 | Jagged 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
KIAA0556 | KIAA0556 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KIF18A | Kinesin family member 18A | Predicted intracellular proteins
| | | | | Tissue enhanced |
KIF18B | Kinesin family member 18B | Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAX1 | Lymphocyte transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
METTL7B | Methyltransferase like 7B | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MYO7A | Myosin VIIA | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NES | Nestin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NKX6-1 | NK6 homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
NSUN7 | NOP2/Sun domain family, member 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PDLIM3 | PDZ and LIM domain 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PDZK1 | PDZ domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R13L | Protein phosphatase 1, regulatory subunit 13 like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PTPRR | Protein tyrosine phosphatase, receptor type, R | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |